Federal Official Gazette
No updates.
ANS news
Health plans now cover hormonal IUD for the treatment of endometriosis
Mandatory coverage by health plans of the hormonal intrauterine device or system (IUD/IUS) for patients with endometriosis takes effect this Thursday, Oct 1. The measure was approved by the National Supplementary Health Agency (ANS) on Sep 18 and will expand the treatment options available to beneficiaries diagnosed with the condition. The update to the List of Health Procedures and Events (Rol) includes the device itself and all procedures for its placement. The hormonal IUD/IUS will be guaranteed to women with endometriosis in cases of contraindication to, or non-adherence to, combined oral contraceptives, as provided in Guideline for Use (DUT) 175, of Annex II of Normative Resolution 465/2021.
Open public consultations
- CP 176. Subject: preliminary recommendations against incorporating the technology covered by UAT No. 184 – Molecular DNA analysis; search for microdeletions by FISH (Fluorescent In Situ Hybridization); microsatellite instability (MSI), detection by PCR, paraffin block, SUBITEM OF DUT – 110.39 – Syndrome of chromosomal anomalies not clinically recognizable (array). Deadline: September 21 to October 10, 2026.
Scheduled public hearings
No public hearing is scheduled.
Open public calls for input
- The call for input addressed to the ombudsman offices of health plan operators, concerning the effectiveness of service channels and the monitoring provided for in RN No. 623/2024, is open until Oct 20, as detailed in item 2.1.
Open public calls
There are no open public calls or targeted social participation processes.
Other news
– No changes.
Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.